Presentation TCT 2013 Recognizing the Need, Building the Tools: EVAR for AAA Presenter: Juan Parodi October 27, 2013
Presentation TCT 2013 LAA Closure is Now Established - The Added Value of New Randomized Trials Would be Minimal! Presenter: Matthew Price October 27, 2013
Presentation TCT 2013 Emerging Technologies for CLI: Advantages to Working Together Presenter: Hiroyoshi Yokoi October 27, 2013
Presentation TCT 2013 ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results Presenter: Ricardo Costa October 27, 2013
Presentation TCT 2013 Strengthening Our National System for Medical Device Postmarket Surveillance Presenter: John Laschinger October 27, 2013
Presentation TCT 2013 Endovascular Management of Popliteal Aneurysms: Tips and Tricks Presenter: Jacques Busquet October 27, 2013
Presentation TCT 2013 Which High-Risk AS Patients Should be Treated with TAVR and Which are Better Suited for Surgical AVR Presenter: Neil Moat October 27, 2013
Presentation TCT 2013 Is Normalized Vasoreactivity at and Distal to the Stent Site Likely to Translate into Improved Clinical Outcomes? Presenter: Raimund Erbel October 27, 2013